Weixiong Zhu

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsMedical mycologyMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Post-Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications.

|Dec 20, 2025
Proton-Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological Pathways.

Weixiong Zhu, Chuanlei Fan, Hongyu Wang

|Nov 22, 2025
Letter to the Editor: Rethinking Myeloperoxidase Inhibition in MASH-Lessons From the COSMOS Trial.

Weixiong Zhu, Wancheng Li, Yuanhui Su

|Sep 03, 2025
Targeting ARPC1B + Cancer Stem Cells to Sensitise Pancreatic Cancer to Gemcitabine Treatment.

Yang Wu, Jianpeng Zhang, Weixiong Zhu

|Aug 01, 2025
MRI Detection of PDAC Response to KRAS Inhibitor Therapy-Letter.

Weixiong Zhu, Ming Li, Run Shi

Pageof 1

Frequent Collaborators

1 joint publications

Ming Li

1 joint publications

Run Shi

1 joint publications

Yang Wu

1 joint publications

Jianpeng Zhang